首页> 外文期刊>Surgical oncology >What should we intend for minimally invasive treatment of colorectal cancer?
【24h】

What should we intend for minimally invasive treatment of colorectal cancer?

机译:对于结直肠癌的微创治疗,我们打算做什么?

获取原文
获取原文并翻译 | 示例
           

摘要

Non-inferiority of laparoscopic treatment of colorectal cancer (CRC) has been demonstrated in randomized controlled trials although operative and perioperative management varies widely among centers. Literature data in English language published up to April 15, 2014 were analyzed in order to give an up to date analysis that would highlights the key aspects of a modern and factual minimally invasive treatment of CRC. Laparoscopic resection is the first choice treatment of colon cancer. Laparoscopic resection of rectal cancer should be considered an investigational procedure to be performed in high volume centers with special interest in laparoscopy and colorectal surgery. Less invasive approaches should be taken into account with the aim of reducing surgical stress. The adoption of ERAS programs has demonstrated to optimize short-term results. Future research should be directed to prove possible long-term advantages, in terms of overall and disease-free survival, of minimally invasive treatment of CRC.
机译:尽管中心之间的手术和围手术期管理差异很大,但在随机对照试验中已经证明了腹腔镜治疗结直肠癌(CRC)的非劣效性。分析了截至2014年4月15日发布的英语文献数据,以便进行最新分析,从而强调现代和事实性的CRC微创治疗的关键方面。腹腔镜切除术是结肠癌的首选治疗方法。腹腔镜直肠癌切除术应被认为是对腹腔镜和结直肠手术特别感兴趣的高容量中心进行的研究性手术。为了减少手术压力,应考虑侵入性较小的方法。已证明采用ERAS计划可以优化短期结果。应针对未来研究进行研究,以证明就CRC的微创治疗而言,在总体生存和无病生存方面具有长期优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号